Latest Lenalidomide Stories

2012-05-16 11:15:14

In Phase III clinical trials, the treatment decreased the risk that the cancer would progress; this positive early result prompted investigators to consider a new standard of care Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid®, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science University Knight Cancer Institute. The study, published...

Word of the Day
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'